MORE-Protokoll veröffentlicht

Early Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study.

Weitere Informationen unter: http://www.researchprotocols.org/2016/2/e124/

Zurück